sFlt-1

Uses

How it works

Where it comes from

Highlighted claims

• sFlt-1 is described as a placental protein. — A new treatment for preterm pre-eclampsia could benefit mother and child
• The reported treatment selectively removes sFlt-1 in preterm pre-eclampsia. — A new treatment for preterm pre-eclampsia could benefit mother and child
• The treatment is designed to reduce a specific circulating placental factor. — A new treatment for preterm pre-eclampsia could benefit mother and child
• The preview implies that sFlt-1 is a disease-relevant treatment target rather than only a biomarker. — A new treatment for preterm pre-eclampsia could benefit mother and child